Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates

Novavax (NVAX) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of$ 0.71 per share. This compares to loss of $1.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 312.68%. A quarter ago, it was expected that this vaccine maker would post a loss of$ 0.75 per share when it actually produced a loss of $0.51, delivering a surprise of 32%.Over the last four quarters, the company has surpasse ...